Evidence map›Paper›PMID 41346419›Full record

ArticleFrontiers in molecular neuroscience2025

Predictive value of circulating SNHG1/miR-194-5p and carotid ultrasound for the onset of cerebral infarction in patients with transient cerebral ischemia.

Wei Wang, Mingjia Lv, Xin Zhang

Abstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wei Wang *Department of Ultrasound Examination, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Mingjia Lv *Department of Ultrasound Examination, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Xin ZhangDepartment of Ultrasound Examination, Shengli Oilfield Central Hospital, Dongying, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transient cerebral ischemia is a strong warning sign of cerebral infarction (CI). Early objective risk assessment in patients with transient cerebral ischemia can effectively help prevent the occurrence of CI. Objective: The study aimed to explore the predictive value of SNHG1/miR-194-5p in combination with carotid ultrasound for predicting the occurrence of CI in patients with transient cerebral ischemia. Patients and methods: This study was a prospective observational study. A total of 189 patients with transient cerebral ischemia were included and divided into the CI group (n = 67) and the non-CI group (n = 122) based on whether CI occurred within 90 days. The clinical data and laboratory indexes of the two groups were compared. RT-qPCR was employed to examine the levels of SNHG1/miR-194-5p. Logistic regression analysis and receiver operating characteristic (ROC) curve analysis were performed based on serum SNHG1/ miR-194-5p levels and the degree of carotid artery stenosis. In addition, bioinformatics analysis was carried out to identify the target genes of miR-194-5p. Results: The results showed that, compared to the non-CI group, the expression of SNHG1 in the serum of the CI group was upregulated, while the expression of miR-194-5p was downregulated. Logistic regression analysis showed that the expression of miR-194-5p (OR = 0.067, Conclusion: Serum SNHG1/miR-194-5p levels combined with carotid ultrasound show high predictive accuracy for the short-term occurrence of CI in patients with transient cerebral ischemia.

Indexed as

carotid ultrasoundcerebral infarctiongenemiR-194-5ptransient cerebral ischemia

Identifiers

PMID41346419
PMCPMC12672895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.